Fresenius stock slips 0.54% to EUR 53.67 before Xetra
Published on 11/17/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSHealthcare portfolio remains central
- Fresenius operates hospitals and develops pharmaceuticals and infusion solutions.
- The company is a member of Germany's DAX index.
Fresenius stock traded at EUR 53.67 on Lang & Schwarz at 07:50 CET on Tuesday, November 17, 2026, 0.54 percent below the Xetra close of Monday, November 16, 2026.
Börse Frankfurt describes Fresenius as a healthcare group operating hospitals and developing pharmaceuticals and infusion solutions.
German market conditions can be followed through the DAX.
Disclaimer...
en | DE000FRE5EN2 | FRESENIUS | boerse | 70525127 | bgmi
